title: Alteration in insulin-like growth factor-binding proteins (IGFBPs) and IGFBP-3 protease activity in serum and urine from acute and chronic renal failure.
abstract: The insulin-like growth factors, IGF-I and IGF-II, are proteins that promote cellular growth and differentiation of various organs, including the kidney. These peptides interact with high affinity cell surface receptors and bind to a family of IGF-binding proteins (IGFBPs). Altered serum and urinary IGFBP patterns in children with chronic renal failure have been previously described. In this study, we evaluated serum and urinary IGFBP profiles in acute renal failure patients (ARF; n = 10) and chronic renal failure patients (n = 10), using Western ligand blots. Most patients with acute or chronic renal failure showed decreased intact serum IGFBP-3 and increased serum IGFBP-2. Both groups displayed marked urinary IGFBP alterations, including increased urinary IGFBP-1 and totally absent urinary IGFBP-3, as detected by Western ligand blot. To evaluate altered IGFBP profiles, we performed IGFBP-3 protease assays with sera and urine from renal failure patients and normal controls. Although control urine had only minor protease activity (defined by the ability to degrade [125I]IGFBP-3), significant protease activity was found in urine from renal failure patients. The proteolytic pattern and susceptibility to protease inhibitors in most renal failure urine samples were the same as those seen in normal urine and with plasmin. Protease activity was completely inhibited by serine protease inhibitors. We speculate that urinary protease activity is mediated primarily by a serine protease(s), which may be involved in the modulation of renal IGF activity in health and disease.
authors.affiliation: Department of Pediatrics, Chonbuk National University Medical School, Chonju, Korea.
authors.forename: D Y
authors.initials: DY
authors.lastname: Lee
authors.forename: S K
authors.initials: SK
authors.lastname: Park
authors.forename: P D
authors.initials: PD
authors.lastname: Yorgin
authors.forename: P
authors.initials: P
authors.lastname: Cohen
authors.forename: Y
authors.initials: Y
authors.lastname: Oh
authors.forename: R G
authors.initials: RG
authors.lastname: Rosenfeld
mesh_terms: D058186:Acute Kidney Injury / Q000097:blood* / Q000652:urine*; D000293:Adolescent; D000328:Adult; D007611:Aprotinin / Q000494:pharmacology; D015153:Blotting, Western; D002352:Carrier Proteins / Q000097:blood* / Q000652:urine*; D002648:Child; D002675:Child, Preschool; D010450:Endopeptidases / Q000097:blood* / Q000652:urine*; D005260:Female; D006801:Humans; D018969:Insulin-Like Growth Factor Binding Proteins; D007676:Kidney Failure, Chronic / Q000097:blood* / Q000652:urine*; D008297:Male; D008875:Middle Aged; D008970:Molecular Weight; D000979:alpha-2-Antiplasmin / Q000494:pharmacology
chemical_list: D002352:Carrier Proteins; D018969:Insulin-Like Growth Factor Binding Proteins; D000979:alpha-2-Antiplasmin; D007611:Aprotinin; D010450:Endopeptidases; C080473:insulin-like growth factor binding protein-3 protease